Literature DB >> 17024555

Prognostic groups in colorectal carcinoma patients based on tumor cell proliferation and classification and regression tree (CART) survival analysis.

Vladimir A Valera1, Beatriz A Walter, Naoyuki Yokoyama, Yu Koyama, Tsuneo Iiai, Haruhiko Okamoto, Katsuyoshi Hatakeyama.   

Abstract

BACKGROUND: In this study, an alternative analytical method was used to model colorectal cancer (CRC) patients' long-term survival by assessing the prognostic value of the Ki-67 protein as a marker of tumor cell proliferation, and to illustrate the interaction between standard clinicopathologic variables and the proliferation marker in relation to their impact on survival.
METHODS: A cohort of 106 surgically treated CRC patients was used for analysis. The expression of the cell-cycle-related Ki-67 protein in tumor samples was evaluated by immunohistochemistry. A score was assigned as the percentage of positive tumor cell staining, denoted as proliferation index (PI), and was used in a multivariate analysis using a recursive partitioning algorithm referred to as classification and regression tree (CART) to characterize the long-term survival after surgery.
RESULTS: Of the covariates selected for their prognostic value, PI contributed most to the classification of survival status of patients. However, CART analysis selected the presence of distant metastasis as the best first split-up factor for predicting 5-year survival. CART then selected the following covariates for building up subgroups at risk for death: (1) PI; (2) pathological lymph node metastasis; (3) tumor size. Seven terminal subgroups were formed, with an overall misclassification rate of 16%.
CONCLUSIONS: These analyses demonstrated that a Ki-67-protein-based tumor proliferation index appeared as an independent prognostic variable that was consistently applied by the CART algorithm to classify patients into groups with similar clinical features and survival.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17024555     DOI: 10.1245/s10434-006-9145-2

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  12 in total

1.  Pretreatment prediction of anemia progression by pegylated interferon alpha-2b plus ribavirin combination therapy in chronic hepatitis C infection: decision-tree analysis.

Authors:  Naoki Hiramatsu; Masayuki Kurosaki; Naoya Sakamoto; Manabu Iwasaki; Minoru Sakamoto; Yoshiyuki Suzuki; Fuminaka Sugauchi; Akihiro Tamori; Sei Kakinnuma; Kentaro Matsuura; Namiki Izumi
Journal:  J Gastroenterol       Date:  2011-06-17       Impact factor: 7.527

2.  Developing screening services for colorectal cancer on Android smartphones.

Authors:  Hui-Ching Wu; Chiao-Jung Chang; Chun-Che Lin; Ming-Chang Tsai; Che-Chia Chang; Ming-Hseng Tseng
Journal:  Telemed J E Health       Date:  2014-05-21       Impact factor: 3.536

3.  Decision tree analysis to stratify risk of de novo non-melanoma skin cancer following liver transplantation.

Authors:  Tomohiro Tanaka; Michael D Voigt
Journal:  J Cancer Res Clin Oncol       Date:  2018-01-23       Impact factor: 4.553

4.  Robust gene expression signature from formalin-fixed paraffin-embedded samples predicts prognosis of non-small-cell lung cancer patients.

Authors:  Yang Xie; Guanghua Xiao; Kevin R Coombes; Carmen Behrens; Luisa M Solis; Gabriela Raso; Luc Girard; Heidi S Erickson; Jack Roth; John V Heymach; Cesar Moran; Kathy Danenberg; John D Minna; Ignacio I Wistuba
Journal:  Clin Cancer Res       Date:  2011-07-08       Impact factor: 12.531

5.  Pretreatment prediction of response to peginterferon plus ribavirin therapy in genotype 1 chronic hepatitis C using data mining analysis.

Authors:  Masayuki Kurosaki; Naoya Sakamoto; Manabu Iwasaki; Minoru Sakamoto; Yoshiyuki Suzuki; Naoki Hiramatsu; Fuminaka Sugauchi; Hiroshi Yatsuhashi; Namiki Izumi
Journal:  J Gastroenterol       Date:  2010-09-10       Impact factor: 7.527

6.  Classification and clustering analysis of pyruvate dehydrogenase enzyme based on their physicochemical properties.

Authors:  Amit Kumar Banerjee; Sunita M; Naveen M; Upadhyayula Suryanarayana Murty
Journal:  Bioinformation       Date:  2010-04-30

7.  Aberrant crypt focus and fragile histidine triad protein in sporadic colorectal carcinoma.

Authors:  Kim Vaiphei; Aruna Rangan; Rajinder Singh
Journal:  World J Gastrointest Oncol       Date:  2012-12-15

8.  Nuclear receptor expression defines a set of prognostic biomarkers for lung cancer.

Authors:  Yangsik Jeong; Yang Xie; Guanghua Xiao; Carmen Behrens; Luc Girard; Ignacio I Wistuba; John D Minna; David J Mangelsdorf
Journal:  PLoS Med       Date:  2010-12-14       Impact factor: 11.069

9.  Which is a more accurate predictor in colorectal survival analysis? Nine data mining algorithms vs. the TNM staging system.

Authors:  Peng Gao; Xin Zhou; Zhen-ning Wang; Yong-xi Song; Lin-lin Tong; Ying-ying Xu; Zhen-yu Yue; Hui-mian Xu
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

10.  A study of gene expression markers for predictive significance for bevacizumab benefit in patients with metastatic colon cancer: a translational research study of the Hellenic Cooperative Oncology Group (HeCOG).

Authors:  George Pentheroudakis; Vassiliki Kotoula; Elena Fountzilas; George Kouvatseas; George Basdanis; Ioannis Xanthakis; Thomas Makatsoris; Elpida Charalambous; Demetris Papamichael; Epaminontas Samantas; Pavlos Papakostas; Dimitrios Bafaloukos; Evangelia Razis; Christos Christodoulou; Ioannis Varthalitis; Nicholas Pavlidis; George Fountzilas
Journal:  BMC Cancer       Date:  2014-02-20       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.